- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02825693
Femtosecond Laser Assisted Cataract Surgery in The NHS
July 22, 2020 updated by: Guy's and St Thomas' NHS Foundation Trust
The Development of Surgical Pathways Using Femto-second Laser Technology to Increase the Efficiency and Safety of Cataract Surgery Within a Public Health Sector Setting - A Randomised Controlled Trial
This study aims to examine the health economic impact of adopting femtosecond laser technology to assist high volume cataract surgery (FLACS) within a state-funded healthcare system, the National Health Service (NHS).
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
400
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients must have reduced visual acuity or visual symptoms attributed to the presence of cataract in one or both eyes by the examining ophthalmologist or else must require cataract surgery on clinical grounds other than visual symptoms.
- Patients must be willing to attend for follow-up at 1 month after cataract surgery.
- Patients must be sufficiently fluent in English for informed consent and self-completion of the patient reported outcome questionnaires.
Exclusion Criteria:
- Children below the age of 18
- Already enrolled in another study
The principle exclusion criteria relate to clinical contraindications for FLACS, such as:
- Significant corneal opacities
- Small pupils following pharmacological dilatation
- Patients unable to lie sufficiently flat so as to be positioned underneath the laser machine.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Femtosecond laser cataract surgery
Cataract surgery with femtosecond laser treatment for corneal incisions, astigmatic keratotomies, capsulotomy and nuclear fragmentation
|
|
Active Comparator: Conventional phacoemulsification surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost-analysis: Healthcare resource use attributable to managing patients in this study will be collected.
Time Frame: up to 2 months
|
These include (but not necessarily be limited to) the cost of surgery for both arms of the trial (including resource use and staffing levels required for the surgical protocols), resource use attributable to managing complications arising from surgery, all relevant diagnostic investigations, further surgery where necessary, hospital length of stay and ward type, outpatient attendances, procedures performed on an outpatient basis, Accident & Emergency attendances and prescribed drug medications.
The quantity of resource use for each cost component will be measured from medical records.
Site-specific unit costs will be taken in preference of standard published sources or national tariffs where possible.
|
up to 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
June 20, 2016
First Submitted That Met QC Criteria
July 4, 2016
First Posted (Estimate)
July 7, 2016
Study Record Updates
Last Update Posted (Actual)
July 23, 2020
Last Update Submitted That Met QC Criteria
July 22, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ILH297-P002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Femtosecond laser assisted cataract surgery
-
University Hospital, BordeauxCompleted
-
Medical University of ViennaCompleted
-
Singapore Eye Research InstituteUnknownVisual OutcomesSingapore
-
Wenzhou Medical UniversityCompleted
-
Kenneth J RosenthalJohnson & Johnson Surgical Vision, Inc.Not yet recruitingCataract | AstigmatismUnited States
-
Steve H. Linn, ODCompletedCortical Cataract | Posterior Subcapsular Cataract | Nuclear Sclerosis of the LensUnited States
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Ziemer Ophthalmic Systems AGRecruiting
-
Ziemer Ophthalmic Systems AGCompleted